Choosing where to play isnt just about flashy graphics
GLP-1 Agonists: Supporting Success with Nutrition and Lifestyle Considerations (1 hour) CE/CME Course #: 25-397 This course reviews clinical evidence for glucagon-like peptide-1 (GLP-1) receptor agonists for conditions including type 2 diabetes and weight loss
If weight loss is your goal, is one extract better than the other
There is an urgent clinical need to explore novel therapeutic targets and strategies [2]
News provided by Eli Lilly and Company May 21, 2026, 06:45 ET In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving 30% weight loss, a level long associated with bariatric surgery Individuals with a baseline BMI 35 who participated in a study extension continued to lose weight, and achieved up to an average of 85.0 lbs (30.3%) weight loss at 104 weeks At the 4 mg dose, reached with only a single escalation step, participants lost an average of 47.2 lbs (19.0%) at 80 weeks with a lower observed discontinuation rate due to adverse events vs
However Health News also warned: Using Ozempic does not come without risks